We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $210B
1-Year Est. Return 57.28%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+6.39%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.63%
5 Year Est. Return
+213.1%
10 Year Est. Return
+910%
AUM
$121B
AUM Growth
+$9.79B
Cap. Flow
-$7.58B
Cap. Flow %
-6.28%
Top 10 Hldgs %
9.24%
Holding
5,958
New
1,032
Increased
1,969
Reduced
1,595
Closed
616

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$986M
2
SE icon
Sea Limited
SE
+$480M
3
SNOW icon
Snowflake
SNOW
+$441M
4
C icon
Citigroup
C
+$422M
5
ORCL icon
Oracle
ORCL
+$393M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$575M
2
AAPL icon
Apple
AAPL
+$515M
3
MA icon
Mastercard
MA
+$506M
4
DIS icon
Walt Disney
DIS
+$447M
5
BABA icon
Alibaba
BABA
+$434M

Sector Composition

Rank Sector Weight
1 Miscellaneous 41.89%
2 Technology 13.97%
3 Consumer Discretionary 9.18%
4 Financials 7.48%
5 Healthcare 7.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OESX icon
4801
Orion Energy Systems
OESX
$114M
$156K ﹤0.01%
4,309
+3,112
+260% +$120K
GLAD icon
4802
Gladstone Capital
GLAD
$437M
$155K ﹤0.01%
6,688
-45
-0.7% -$1.04K
ROOT icon
4803
CALL
Root
ROOT
$812M
$155K ﹤0.01%
+2,778
New +$217K
OPAD icon
4804
Offerpad Solutions Inc. Class A Common Stock
OPAD
$16.8M
$154K ﹤0.01%
160
-202
-56% -$232K
DMAQR
4805
DELISTED
Deep Medicine Acquisition Corp. Rights
DMAQR
$154K ﹤0.01%
+480,000
New +$152K
ATNM icon
4806
Actinium Pharmaceuticals
ATNM
$39M
$153K ﹤0.01%
25,473
-2,646
-9% -$19.9K
JAKK icon
4807
Jakks Pacific
JAKK
$277M
$153K ﹤0.01%
15,062
-12,187
-45% -$136K
MBAC.WS
4808
DELISTED
M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MBAC.WS
$153K ﹤0.01%
131,498
RPT
4809
Rithm Property Trust
RPT
$91.3M
$152K ﹤0.01%
1,926
-1,240
-39% -$101K
BNGO icon
4810
Bionano Genomics
BNGO
$17.8M
$151K ﹤0.01%
+84
New +$225K
TMAC.WS
4811
DELISTED
The Music Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
TMAC.WS
$151K ﹤0.01%
269,562
ASUR icon
4812
Asure Software
ASUR
$244M
$150K ﹤0.01%
19,192
+4,340
+29% +$37.9K
LITS
4813
Lite Strategy Inc
LITS
$34.7M
$150K ﹤0.01%
+2,810
New +$157K
XOS icon
4814
Xos
XOS
$35.7M
$150K ﹤0.01%
1,585
-31,748
-95% -$3.92M
EIGR
4815
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$150K ﹤0.01%
+966
New +$187K
GOL
4816
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
$150K ﹤0.01%
24,800
JMACW
4817
DELISTED
Maxpro Capital Acquisition Corp. Warrants
JMACW
$150K ﹤0.01%
+375,000
New +$151K
AYTU icon
4818
AYTU BioPharma
AYTU
$21.1M
$148K ﹤0.01%
5,482
-4,186
-43% -$181K
BTTX
4819
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
$148K ﹤0.01%
+31,848
New +$261K
APGB.WS
4820
DELISTED
Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
APGB.WS
$148K ﹤0.01%
156,051
MSDAW
4821
DELISTED
MSD Acquisition Corp. Warrant
MSDAW
$147K ﹤0.01%
128,230
-11,770
-8% -$14.6K
GLRE icon
4822
Greenlight Captial
GLRE
$494M
$146K ﹤0.01%
18,569
-32,712
-64% -$240K
AONCW
4823
DELISTED
American Oncology Network, Inc. Warrant
AONCW
$146K ﹤0.01%
220,646
ALDX icon
4824
Aldeyra Therapeutics
ALDX
$82.6M
$145K ﹤0.01%
36,228
+21,947
+154% +$167K
KNSA icon
4825
Kiniksa Pharmaceuticals
KNSA
$6.06B
$145K ﹤0.01%
+12,317
New +$151K

Similar funds

D.E. Shaw & Co's Q4 2021 Portfolio in Review

As of Q4 2021, D.E. Shaw & Co held 5,958 positions worth $121B, up 8.8% from $111B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

D.E. Shaw & Co withdrew a net $7.58B in Q4 2021, closing 616 positions and reducing 1,595 holdings. Its most notable exit was Aon, an estimated $179M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 38% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, D.E. Shaw & Co opened a new position in iShares Core S&P 500 ETF worth $1.02B.

  • D.E. Shaw & Co's largest Q4 2021 buy was iShares Core S&P 500 ETF: 2,140,000 shares worth $1.02B.
  • D.E. Shaw & Co added most to Sea Limited in Q4 2021, an estimated $480M increase.
  • D.E. Shaw & Co's biggest Q4 2021 reduction was Microsoft, cutting an estimated $575M.
  • D.E. Shaw & Co fully exited Aon in Q4 2021, selling an estimated $179M.
  • D.E. Shaw & Co's ten largest holdings make up 9.2% of its $121B portfolio in Q4 2021.
  • D.E. Shaw & Co opened 1,032 new positions and closed 616 in Q4 2021.
  • D.E. Shaw & Co's portfolio value rose 8.8% quarter-over-quarter to $121B.

Based on D.E. Shaw & Co's 13F filing for Q4 2021, filed 14 Feb 2022.